AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming
Non-small cell lung cancer (NSCLC) ranks first among cancer death worldwide. Despite efficacy and safety priority, targeted therapy only benefits ∼30% patients, leading to the unchanged survival rates for whole NSCLC patients. Metabolic reprogramming occurs to offer energy and intermediates for fuel...
Main Authors: | Chang, L.-L (Author), Hu, Y. (Author), Lin, N.-M (Author), Lu, P.-H (Author), Yang, W. (Author), Zhang, W.-Z (Author), Zhao, Q. (Author), Zheng, L. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Neoplasia Press, Inc.
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells
by: Tian H, et al.
Published: (2016-05-01) -
Expression of the Aldo-Keto Reductases AKR1B1 and AKR1B10 in Human Cancers.
by: Brian eLaffin, et al.
Published: (2012-06-01) -
Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma
by: Wang L, et al.
Published: (2019-01-01) -
MiR-935/HIF1α Feedback Loop Inhibits the Proliferation and Invasiveness of Glioma
by: Huang G, et al.
Published: (2020-10-01) -
Pleiotropic Actions of Aldehyde Reductase (AKR1A)
by: Junichi Fujii, et al.
Published: (2021-05-01)